| Gene | |
|---|---|
| **Symbol** | RPL10 |
| **Full Name** | Ribosomal Protein L10 |
| **Chromosome** | Xq28 |
| **NCBI Gene ID** | 6135 |
| **UniProt ID** | [P83731](https://www.uniprot.org/uniprotkb/P83731) |
| **Ensembl** | [ENSG00000149499](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000149499) |
| **Protein Class** | Ribosomal protein, large subunit |
| **Alternative Names** | L10, QM, DXS983 |
RPL10 (Ribosomal Protein L10) encodes a component of the large (60S) ribosomal subunit essential for protein synthesis in all cells, including neurons. Originally identified as a tumor suppressor (QM protein), RPL10 has gained attention for its role in neurodegenerative diseases through connections to translation regulation, ribosomal dysfunction, and protein homeostasis failures that are central to Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis 1.
Mutations in RPL10 and related ribosomal proteins cause X-linked intellectual disability and have been implicated in autism spectrum disorders, highlighting the importance of proper ribosomal function in neurodevelopment 2. This page provides a comprehensive overview of RPL10's molecular function, disease associations, and therapeutic implications.
RPL10 is a component of the 60S large ribosomal subunit, one of two subunits that comprise the ribosome 3:
Ribosome Structure:
┌─────────────────┐
│ 40S Small │ ← 18S rRNA + 33 proteins
│ Subunit │
└────────┬────────┘
↓ mRNA
┌────────┬────────┐
│ 60S Large │ ← 28S rRNA + 5.8S rRNA + 5S rRNA + ~47 proteins
│ Subunit │ (including RPL10)
└─────────────────┘
↓
Polypeptide chain
RPL10 is located at the subunit interface and plays critical roles in:
- Ribosome assembly: Proper folding and assembly of the 60S subunit
- Translation elongation: Stabilization of tRNA binding
- Ribosome quality control: Detection of stalled or defective ribosomes
- Polysome formation: Assembly of translation-active polysomes
RPL10 interacts with several key proteins 4:
| Partner |
Interaction |
Function |
| RPL5 |
Direct binding |
Ribosome assembly |
| RPL11 |
Direct binding |
Ribosome assembly |
| MDM2 |
Via RPL5/RPL11 |
p53 regulation |
| c-MYC |
Transcriptional |
Translation regulation |
| eIF6 |
Antagonistic |
Translation initiation |
The ribosome is the molecular machine that translates mRNA into protein. RPL10 contributes to 5:
- Peptidyl transferase activity: Catalyzes peptide bond formation
- tRNA positioning: Stabilizes tRNA in the P and A sites
- Elongation factor binding: Interacts with eEF-1 and eEF-2
- Termination: Release factor recognition
- Recycling: Ribosome dissociation after termination
RPL10 and ribosomal dysfunction contribute to neurodegeneration through translation dysregulation 6:
Ribosomal dysfunction
↓
Global translation decline
↓
Proteostasis failure
↓
Stress granule formation
↓
Neuronal vulnerability
↓
Cell death
Key mechanisms include:
- Global translation reduction: Impaired protein synthesis capacity
- Selective translation failure: Failure to translate specific mRNAs
- Ribosome stalling: Accumulation of stalled translation complexes
- Polysome disaggregation: Loss of translation-active complexes
- RQC activation: Ribosome quality control pathway activation
The protein homeostasis (proteostasis) pathway is critical for neuronal health, and RPL10 dysfunction contributes to its failure 7:
Protein synthesis defects:
- Decreased synthesis of synaptic proteins
- Impaired activity-dependent translation
- Failure to replace damaged proteins
Misfolded protein accumulation:
- Defective ribosomal products (DiP)
- Aggregated protein inclusions
- Impaired autophagy
Translation of toxic proteins:
- Increased amyloid-beta synthesis
- Enhanced tau phosphorylation
- Alpha-synuclein overexpression
Ribosomal dysfunction triggers stress granule formation, which is implicated in neurodegeneration 8:
- Stress granules are RNA-protein aggregates that form when translation is inhibited
- Persistent stress granules become pathological inclusions
- TDP-43 and FUS co-localize with stress granules
- Stress granule dynamics are altered in ALS, FTD, and AD
Neurons are particularly vulnerable to ribosomal dysfunction due to their reliance on local translation for synaptic function 9:
- Synaptic plasticity requires rapid protein synthesis
- RPL10 dysfunction impairs synaptic protein synthesis
- Memory consolidation is translation-dependent
- Synaptic scaling requires new protein synthesis
Ribosomal stress triggers apoptotic pathways through several mechanisms 10:
- p53 activation: RPL10/RPL5 loss releases MDM2 inhibition
- eIF2α phosphorylation: Integrated stress response activation
- BAX activation: Mitochondrial apoptotic pathway
- Caspase activation: Execution of apoptosis
RPL10 and ribosomal dysfunction play significant roles in Alzheimer's disease pathogenesis 11:
Evidence:
- Ribosomal RNA levels decreased in AD brain
- Translation efficiency impaired in AD neurons
- RPL10 expression altered in hippocampus
- Synaptic ribosomes particularly vulnerable
Mechanisms:
- Amyloid-beta impairs translation machinery
- Tau pathology disrupts ribosomal function
- Energy deficits reduce translation capacity
- ER stress inhibits translation
In Parkinson's disease, ribosomal dysfunction contributes to dopaminergic neuron vulnerability 12:
- Alpha-synuclein aggregates interfere with translation
- Mitochondrial dysfunction affects ribosomal maintenance
- RPL10 variants may modify PD risk
- Protein synthesis capacity declines with age
RPL10 variants have been identified in ALS patients 13:
- Ribosomal protein mutations in familial ALS
- Translation defects in motor neurons
- Stress granule pathology
- C9orf72 repeat stress affects translation
RPL10 mutations cause X-linked intellectual disability (XLID) through impaired ribosomal function 14:
- RPL10 variants identified in families with ID
- Impaired neurite outgrowth
- Synaptic dysfunction
- Behavioral phenotypes
RPL10 is implicated in autism spectrum disorder through translation regulation 15:
- RPL10 mutations in ASD patients
- Altered synaptic translation
- Social behavior deficits in models
- Interaction with fragile X pathway
RPL10 is ubiquitously expressed with high levels in metabolically active cells:
| Tissue |
Expression Level |
| Brain |
High (neurons) |
| Liver |
High |
| Kidney |
High |
| Heart |
Moderate-high |
| Skeletal muscle |
Moderate |
| Lung |
Moderate |
In the brain, RPL10 is expressed in:
The high expression in neurons reflects their critical dependence on protein synthesis for synaptic function and plasticity 16.
Targeting translation pathways may benefit neurodegenerative diseases 17:
- eIF2α modulators: ISRIB, integrated stress response inhibitors
- mTOR inhibitors: Rapamycin, rapamycin analogs
- Translation activators: eIF4E targeting compounds
- Ribosome stabilizers: Small molecules to enhance ribosomal function
RPL10 represents a potential target for gene therapy in ribosomal disorders:
- Wild-type RPL10 delivery
- Splice-switching oligonucleotides
- CRISPR-based correction
- miRNA-mediated regulation
Pharmacological approaches to enhance ribosomal function:
- Ribosome assembly enhancers
- Translation elongation promoters
- Antioxidants to reduce ribosomal stress
- Mitochondrial function enhancers
¶ Variants and Pathogenicity
| Variant Type |
Examples |
Associated Phenotype |
| Missense |
p.Arg98Cys, p.Pro94Leu |
Intellectual disability |
| Nonsense |
p.Tyr226Ter |
Intellectual disability |
| Splice site |
c.505-1G>A |
Intellectual disability |
| Frameshift |
c.350delC |
Intellectual disability |
RPL10 is located on the X chromosome (Xq28), and pathogenic variants follow X-linked inheritance 18:
- Males (XY) are affected (hemizygous)
- Females (XX) are typically carriers
- Female carriers may have mild symptoms (skewed X-inactivation)
- 50% chance of carrier status in daughters
- RPL10 is highly conserved across species
- Minor allele frequencies for pathogenic variants are very low
- Founder mutations identified in certain populations
RPL10 interacts with other ribosomal proteins in the 60S subunit 19:
- RPL5 (ribosomal assembly)
- RPL11 (ribosomal assembly)
- RPL23 (ribosomal stability)
- RPL39 (ribosomal function)
RPL10 participates in several signaling pathways:
- p53 pathway (via MDM2)
- mTOR signaling (translation regulation)
- Integrated stress response (eIF2α phosphorylation)
- c-MYC transcriptional program
Rpl10 knockout mice are embryonic lethal, highlighting its essential function:
- Rpl10 deletion causes early embryonic death
- Heterozygous mice show subtle phenotypes
- Conditional knockouts in brain show translation defects
Zebra fish provide accessible models for studying RPL10:
- Morpholino knockdown causes developmental defects
- Behavioral deficits in models
- Rescue experiments demonstrate function
Drosophila and C. elegans models reveal evolutionarily conserved functions:
- Homologs: RpL10 in Drosophila, rpl-10 in C. elegans
- Loss-of-function causes neurological phenotypes
- Useful for genetic modifier screens
- QM protein identification: RPL10 originally identified as tumor suppressor QM
- X-linked ID discovery: RPL10 mutations cause intellectual disability
- Ribosomal stress: RPL10 dysfunction triggers p53 activation
- Synaptic translation: Critical role in synaptic plasticity
- Neurodegeneration: Translation defects in AD, PD, ALS
RPL10 assembly follows a coordinated pathway 20:
Pre-rRNA transcription (nucleolus)
↓
Early assembly (40S precursor)
↓
Late assembly (60S precursor)
↓ RPL10 incorporation
Mature 60S subunit
↓
80S ribosome formation
RPL10 contributes to several translation regulation mechanisms:
- Initiation: eIF binding to 40S subunit
- Elongation: eEF-mediated translocation
- Termination: Release factor recognition
- Recycling: Ribosome dissociation
Ribosomal quality control pathways monitor RPL10 function:
- No-go decay: Stalled ribosome clearance
- Non-stop decay: mRNA lacking stop codon
- Ribosome-associated quality control: Co-translational monitoring
- RQC: Listerin-dependent decay of incomplete proteins
Genetic testing for RPL10 variants:
- Targeted sequencing
- Whole exome sequencing
- X-chromosome panel
Biochemical markers:
- Translation efficiency in lymphoblasts
- Ribosome assembly analysis
- p53 activation markers
For RPL10-related disorders:
- Supportive care for intellectual disability
- Behavioral interventions
- Physical therapy
- Speech therapy
For neurodegenerative disease overlap:
- Translation-targeted therapeutics
- Symptomatic treatment
- Disease-modifying strategies in development
- Ribosomal biology: Understanding RPL10's role in ribosome assembly
- Neurodegeneration mechanisms: Translation defects as therapeutic targets
- Genetic modifiers: Identifying genetic modifiers of ribosomal dysfunction
- Small molecule screening: Finding compounds that enhance ribosomal function
- Biomarker development: Translation efficiency as disease biomarker
- What determines neuronal specificity of ribosomal dysfunction?
- Can ribosomal function be restored in adult neurons?
- What is the relationship between RPL10 and other ribosomal proteins in disease?
- How does aging interact with ribosomal dysfunction?
- What are the best targets for translation-based therapy?
- Ribosome profiling: Genome-wide analysis of translation
- Single-cell ribosome sequencing: Cellular resolution of translation
- CRISPR screening: Genetic modifiers of ribosomal stress
- Organoid models: Human brain models for RPL10 studies
Ribosome biogenesis is a complex process that occurs primarily in the nucleolus 21:
Stage 1: Pre-rRNA transcription
- RNA Pol I transcribes 45S pre-rRNA
- Processing begins co-transcriptionally
- Early spacing elements required
Stage 2: Early processing
- 45S cleavage generates 18S (40S) and 28S/5.8S/5S (60S) precursors
- Small subunit processome assembly
- U3 snoRNA interactions
Stage 3: Late processing
- 60S subunit maturation
- RPL10 incorporation (late step)
- Nuclear export
Stage 4: Cytoplasmic maturation
- Final processing steps
- Quality control checks
- Translation competence
RPL10 incorporation is a critical late step in 60S maturation. Defects in RPL10 incorporation lead to:
- Pre-60S accumulation
- Nuclear export defects
- Ribosome assembly stress
The ribosome acts as a quality control checkpoint for protein synthesis 22:
Stalled ribosome rescue:
- Ribosome stalling detected
- RQC recruited (Listerin, Rqc2)
- Nascent chain poly(A) tail addition
- Ribosome disassembly
- Nascent chain degradation
Non-stop decay:
- Stop codon absence detected
- Dom34/Hbs1 recruitment
- Ribosome rescue
- mRNA decay
No-go decay:
- Stalling at rare codon detected
- Endonucleolytic cleavage
- tRNA release
- mRNA decay
RPL10 dysfunction impairs these quality control mechanisms, leading to:
- Defective translation products
- Ribosome collision stress
- Proteostatic overload
¶ RPL10 and the Unfolded Protein Response
Misfolded proteins trigger the unfolded protein response (UPR) 23:
ER UPR:
- IRE1 activation
- XBP1 splicing
- ATF6 activation
Cytosolic UPR:
- eIF2α phosphorylation
- ATF4 translation
- CHOP expression
RPL10 dysfunction activates the cytosolic UPR through:
- Accumulation of misfolded proteins
- Ribosome-associated stress
- Proteasome overload
Cross-talk between ribosomes and mitochondria involves 24:
Mitochondrial translation:
- Mitochondrial ribosomes (mitoribosomes)
- Distinct from cytoplasmic ribosomes
- Essential for ETC complex assembly
Energy coupling:
- ATP required for translation
- NADH/ATP ratio affects translation
- Mitochondrial dysfunction impairs translation
Mitophagy:
- Damaged mitochondria cleared by mitophagy
- Translation stress triggers mitophagy
- Quality control at organelle level
RPL10 affects mitochondrial function indirectly through:
- Cellular energy status
- Calcium homeostasis
- Apoptotic signaling
RPL10 is highly conserved across eukaryotes 25:
| Species |
RPL10 Homolog |
Identity |
| Human |
RPL10 |
100% |
| Mouse |
Rpl10 |
99% |
| Zebra fish |
rpl10 |
87% |
| Drosophila |
RpL10 |
71% |
| C. elegans |
rpl-10 |
62% |
| Yeast |
Rpl10p |
55% |
This conservation reflects essential function in ribosome biology.
- Mice: Embryonic lethal knockout, heterozygotes viable
- Zebra fish: Developmental defects, behavioral changes
- Drosophila: Flight defects, neurodegeneration
- C. elegans: Movement defects, reduced lifespan
- Yeast: Growth defects, translation impairment
| Model |
Advantages |
Limitations |
| Yeast |
Fast, genetic tractable |
Evolutionary distance |
| C. elegans |
Neurons, behavior |
Limited genetics |
| Drosophila |
Genetics, neurons |
Limited tissue types |
| Zebra fish |
Development, imaging |
Brain complexity |
| Mouse |
Mammalian physiology |
Cost, time |
RPL10-related intellectual disability:
- Rare: <1:100,000
- Majority of cases are sporadic
- Family history sometimes positive
RPL10 in neurodegenerative disease:
- Not directly causative
- May be modifier gene
- Risk contribution unclear
- Cases reported worldwide
- Founder mutations in specific populations
- Most variants are private
- Intellectual disability: Diagnosed in childhood
- Neurodegeneration: Adult onset
- Modifier effects: Variable age of onset
- Diagnostic testing: $1,000-5,000 per patient
- Management: $10,000-50,000 annually
- Research funding: $10M+ annually
- Caregiver burden significant
- Educational interventions costly
- Lost productivity
- Translation enhancers: Small molecules to boost translation
- Ribosome stabilizers: Compounds to stabilize ribosomal function
- Gene therapy: Viral delivery of wild-type RPL10
- Antisense oligonucleotides: Splice-correcting ASOs
- CRISPR editing: Precise correction of pathogenic variants
- Translation efficiency in blood cells
- Ribosome assembly markers
- Stress granule quantification
- Polysome profiling
- Preimplantation genetic testing
- Prenatal diagnosis for carriers
- Newborn screening for at-risk populations